Biopsychosocial self-management was associated with significant but small reductions in disability in patients with acute low back pain.
An update from Mesoblast Limited ( (AU:MSB) ) is now available.
FDA has designated rexlemestrocel-L a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of chronic low back pain. RMAT designation provides all the benefits of Breakthrough and Fast ...
Chronic pain affects more than 50 million Americans, yet for decades, treatment options for pain that persists in the absence ...
After a slip on the ice, a sports injury, even surgery, most people’s instinct is to rest what hurts. “When you have an acute ...
Spinal cord stimulators can significantly improve patients' lives. The province doesn't fund nearly enough of them, experts ...
When you have an acute injury, your body is sending signals through the peripheral and central nervous systems and the immune ...
Around 80% of people suffer from back pain, but are we treating it wrong? Expert Juanma Ortega shares the secrets to ...
Most of us have grown up hearing the same lines about old age. “He’s old, that’s why he can’t sleep.” “Body pains are normal ...
Preferential MOP agonists such as oxycodone are often required for effective management of moderate to severe pain but come with significant risks of addiction and overdose - ...
Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...
It’s the leading cause of disability and one of the most costly health challenges of our time: chronic lower back pain. Yet effective and safe treatments are few and far between, leading patients to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results